Exelixis Inc. buy BiotechBee
Start price
08.09.24
/
80%
€23.18
Target price
31.12.26
€30.00
Performance (%)
45.56%
End price
14.12.24
€33.74
Summary
This prediction ended on 14.12.24 with a price of €33.74. With a performance of 45.56% the BUY prediction by BiotechBee was a big success. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Exelixis Inc. | 4.493% | 4.493% | 22.910% |
| iShares Core DAX® | 0.224% | 2.457% | 21.634% |
| iShares Nasdaq 100 | 0.371% | -0.320% | 5.422% |
| iShares Nikkei 225® | 0.972% | -0.829% | 15.333% |
| iShares S&P 500 | 0.417% | -0.157% | 3.125% |
According to BiotechBee what are the pros and cons of Exelixis Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Exelixis Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Exelixis Inc.
Buy beendet

